三、主要科研工作与成绩 一、承担项目: 1. DC和TAMs双靶向共载mRNA/siRNA脂质纳米疫苗水凝胶激活适应性免疫和天然免疫治疗肝癌研究(国家自然科学基金面上项目,项目批准号:82072051)第1位 55万 2021.01~2024.12.(在研) 2. 靶向树突状细胞的肝癌干细胞RNA脂质体疫苗的抗肝癌作用和机制研究(国家自然科学基金面上项目,项目批准号:81771964)第1位 60万 2018.01~2021.12.(已结题) 3. 非病毒载体基因治疗恶性肿瘤方案研究(十二五国家高技术研究发展计划(863计划)子课题,课题编号:2012AA020809)第1位 100万 2012.1~ 2015.12. (已结题) 4. 共载盐霉素和自噬相关基因siRNA的CRGDK肽修饰纳米脂质体的抗肝癌作用和机制研究(国家自然科学基金面上项目. 项目批准号:81472829)第1位 64 万2015.01~2018.12. (已结题) 5. 多级肿瘤靶向纳米载体的抗肿瘤作用及其机制研究(国家自然科学基金青年科学基金项目.项目批准号:30901777)第1位 20 万2010.01~2012.12. (已结题) 6. 新型智能温度/pH双敏感免疫脂质体多重靶向递送siRNA治疗乳腺癌研究(2012年度上海市青年科技启明星计划. 课题编号:12QB1402400)第1位 20万 2012.9.1-2014.8.31 (已结题) 7. 负载siRNA的EGFR靶向纳米阳离子脂质体的抗乳腺癌作用及机制研究(上海市教委晨光计划 2011CG41)第1位 6万 2011.6.1~2013.6.1(已结题) 8. 包裹紫杉醇的PLGA靶向纳米药物的制备和抗肿瘤作用研究(上海市国际科技合作基金. 项目批准号:09540703700)第1位 15 万2009.10~2011.9. (已结题) 9. 肝癌靶向抗体偶联纳米颗粒的制备和抗肿瘤机制研究(上海市自然科学基金. 课题编号:09ZR1439900)第1位 10万 2009.8.1-2012.7.31 (已结题)
二、发表文章(近三年) Zhang X#, Cui H#, Zhang W#, *Li Z, *Gao J. Engineered tumor cell-derived vaccines against cancer: the art of combating poison with poison. Bioactive Materials. 2023;22:491-517 (IF: 18.9) Pang L#, Jin H#, Lu Z#, Xie F, Shen H, Li X, Zhang X, Jiang X, Wu L, Zhang M, Zhang T, Zhai Y, Zhang Y, Guan H, *Su J, *Li M*, *Gao J. Treatment with mesenchymal stem cell-derived nanovesicle-containing gelatin methacryloyl hydrogels alleviates osteoarthritis by modulating chondrogenesis and macrophage polarization. Advanced Healthcare Materials. 2023;12(17):e2300315. (IF: 11.1, 封面文章) Li Y#, Wang L#, Zhong G#, Wang G#, Zhu Y#, Li J, Xiao L, Chu Y, *Wu Y, *Li K, *Gao J. Size-Transformable Nanoparticles with Sequentially Triggered Drug Release and Enhanced Penetration for Anticancer Therapy. Nano Research. 2023,16(8):11186-11196. (IF: 10.3, 封面文章) YuanX#, YangW#, FuY#, TaoZ, XiaoL, ZhengQ, WuD, ZhangM, LiL, LuZ*, WuY*, Gao J*,Li Y*. Four-arm polymer-guided formation of curcumin-loaded flower-like porous microspheres as injectable cell carriers for diabetic wound healing. Advanced Healthcare Materials. 2023 Aug 9;e2301486. (IF: 10.3, 封面文章) Feng Y#, Chen Q#, Jin C#, Ruan Y, Chen Q, Lin W, Zhu C, Zhang T, Zhang Y*, Gao J*, Mo J*. Microwave-activated Cu-doped zirconium metal-organic framework for a highly effective combination of microwave dynamic and thermal therapy. J Control Release. 2023;361:102-104. (IF: 10.8) Jiang X#, Wu L#, Zhang M#, Zhang T, Chen C, Wu Y*, Yin C*, Gao J*. Biomembrane nanostructures for chemoimmunotherapy: from delivering chemotherapeutic agents to enhanced tumor immunotherapy. J Controlled Release. 2023;361;510-533. (IF: 10.8) Zheng K, Feng Y, Li L, Kong F, Gao J*, Kong X*. Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors. Theranostics. 2023; doi:10.7150/thno.85917 (IF: 12.4) Yang Y#, Zhu Y#, Wang K#, Chen Q, Miao Y, Zhang Y, *Gao J, *Qin H, *Zhang Y. Activation of Autophagy by in situ Zn2+ Chelation Reaction for Enhanced Tumor Chemo-Immunotherapy. Bioactive Materials 2023;29:116-131 (IF: 18.9) Cui H#, Zhang X#, Zhang Z#, Zhang M, Zhang T, Wu L, Lu Z, *Gao J, *Zhang W. Killing Three Birds with One Stone: Tumor-Membrane-Decorated Prussian Blue Nanovaccines for Synergistic Management of Skin Tumors, Radiation Dermatitis and Wounds. Composites Part B 2023;264:110900. (IF:13.1) Li W#, Bei Y#, Pan X#, Zhu J, Zhang Z, Zhang T, Liu J, Wu D, *Li M, *Wu Y, *Gao J. Selenide-linked Polydopamine-Reinforced Hybrid Hydrogels with On-demand Degradation and Light-triggered Nanozyme Release for Diabetic Wound Healing. Biomaterials Research. 2023;27(1):49. doi: 10.1186/s40824-023-00367-w. (IF: 15.8) WuY#, SuM#, ZhangS#, XiaoL, XiaoY, ZhangM, BeiY, LiM, ZhangF, YuanQ, WuS, LiuJ, LiH, YuanX*, LiM*, LiY*, *Gao J. A Mesenchymal Stem Cell-derived Nanovesicle-Biopotentiated Bovine Serum Albumin-Bridged Gelatin Hydrogel for Enhanced Diabetic Wound Therapy. Materials & Design. 2023:230:111960 (IF: 9.4) Zhang Z#, Cui H#, Zhang T#, Zhang M, Wu L, Zhang X, Zhou X, Li Xi, Zhai Y, Lu Z*, Xu C*, Yin C*, Gao J*. Biomembrane and metal nanostructures for cancer theranostics: The state of the art in the combination of organic and inorganic chemistry. Materials & Design. 2023:231:112067 (IF: 9.4) Yin T, Liu Y, He B, Gong B, Chu J, Gao C, Liang W, Hao M, Sun W, Zhuang J*, Gao J*, Yin Y*. Cell primitive-based biomimetic nanomaterials for Alzheimer’s Disease targeting and therapy. Materials Today Bio 2023:22:100789. (IF: 8.2) Yan Z#, Zhang T#, Wang Y, Xiao S*, Gao J*. Extracellular vesicle biopotentiated hydrogels for diabetic wound healing: the art of living nanomaterials combined with soft scaffolds. Materials Today Bio 2023:23:100810. (IF: 8.2) XinZ, ZhangM, CuiH, DingX,ZhangT, WuL, Cui H, XueQ, ChenC, Gao J*. Algae: A robust living material against cancer. Int J Nanomedicine. 2023:18:5243-5264. (IF: 8.2). Wu Y, Li L, Ning Z, Li C, Yin Y, Chen K, Li L, Xu F, Gao J*. Autophagy-modulating Biomaterials: Multifunctional Weapons to Promote Tissue Regeneration. Cell Communication and Signaling. 2023 (Accepted. IF: 8.2). Liu W#, Wu L#, Chen C#, Zheng H, *Gao J, * Lu Z, * Li M. Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against Tumors. Materials Today Bio 2023:22;100751 (IF: 8.2) Yin T#, Liu Y#, Ji W#, Zhuang J, Chen X, Gong B, Chu J, Liang W, *Gao J, *Yin Y. Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer’s disease. Theranostics. 2023; 13(4):1264-1285. (IF: 11.6) Zhang S, Xie F, Li K, Zhang H, Yin Y, Yu Y, Lu G, Zhang S, Wei Y, Xu K, Wu Y, Jin H, Xiao L, Bao L, *Xu C, *Li Y, *Lu Y, *Gao J. Gold Nanoparticle-Directed Autophagy Intervention for Antitumor Immunotherapy via Inhibiting Tumor Associated Macrophage M2 Polarization. Acta Pharmaceutica Sinica B. 2022;12(7):3124-3138 (IF: 14.9) Zhang Y, Chen Q, Zhu Y, Pei M, Wang K, Qu X, *Zhang Y, *Gao J, *Qin H. Targeting inorganic nanoparticles to tumors using biological membrane-coated technology. Medcomm. 2022;3;e192. (IF: 9.9) Xu X, Liu H, Wang S, Hua Y, Huang B, Li M, *Gao J, Wang X*, Su J*. Neutrophil-Erythrocyte Hybrid Membrane-coated Hollow Copper Sulfide Nanoparticles for Targeted and Photothermal/Anti-inflammatory Therapy of Osteoarthritis. Composites Part B. 2022;237,109855 (IF:11.3) (ESI高被引论文) Lai Y, Wei W, Du Y, *Gao J, Li Z. Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives. Gut Microbes. 2022;14(1):2120747. (IF:10.2)
三、出版专著 1. 生物医用材料:组织修复与肿瘤治疗. 主编:高洁,李玉林,武艳. 上海交大出版社,待出版 2. Jie Gao; Bohua Li; Wei Li; Jianxin Dai; Hao Wang; Yajun Guo. Chapter 8 - Targeted Nanomedicines Conjugated with HER2 Antibodies in Cancer Therapy. HER2 and Cancer: Mechanism, Testing and Targeted Therapy. pp. 175-185. Editor: Sophie I. Williams and Christopher E. Rogers. Nova Science Publishers, Inc., pp 175-185, USA, 2011 2nd quarter, ISBN: 978-1-61122-650-8. 3. Gao J, Zhong YQ. Chapter 16 - HER2-specific PEGylated Immunoliposomes Prepared by Lyophilization/Rehydration Method. Liposome-Based Drug Delivery Systems. Springer Berlin Heidelberg. 2019. ISBN: 3662493187, 9783662493182. 4. 医学起源与发展简史. 主编:苏佳灿,黄标通,许金廉,徐顺清;副主编:顾伟,徐灿,王晓梅,高洁,井莹莹;编委:崔进,董昕,葛文松,耿振,顾超,何世鹏,胡宏岗,胡衍,吕朝阳,曲星宇,宋歌,苏笠,孙宝玉,王思成,王子骁,杨烁,于明香,余越,张艳鹏,钟山,周剑平.上海大学出版社. 2020年5月第一版
四、授权专利 1. 钟延强;陈怀文;郭亚军;高洁;鲁莹;张翮;张欣荣;寇庚;樊莉;孙治国。人源化单克隆抗体Trastuzumab修饰的包裹毒素蛋白的靶向纳米粒及其制备与应用。专利号:ZL 200810035706.6,公开/公告日期: 2011.02.16 2. 钟延强;钟威;郭亚军;高洁;张翮;鲁莹;李博华;方晨;周闺臣;孙霁;邹豪;孙治国;王江峰;王明娟;刘青锋;陈婷;宣吉明。Trastuzumab修饰的包裹毒素蛋白的PEG化免疫脂质体及其制备与应用。专利号:ZL200910050033,公开/公告日期: 2011.11.09 3. 梅其勇;萧文泽;高洁;隋明星;蒋英;江海林;孙正望;侯立军。一种载有辛伐他汀纳米涂层的颅内血管支架。专利号:ZL 201320803589.X,公开/公告日期:2014.07.02 4. 刘艳;陈婷;尹又;高洁;陈霁晖。一种培美曲塞脂质体及其制备方法。专利号:ZL 201510072663.9,公开/公告日期:2015.02.11 5. 鲁莹;钟延强;巩志荣;张翮;高洁;文玺凯;张思悦;陈大中;耿雯倩;张叶叶;王美平。共载盐霉素钠与阿霉素纳米脂质体及其制备方法与应用,专利号:ZL 201510726229.8,公开/公告日期:2018.08.07 6. 鲁莹,钟延强,王美平,张翮,高洁,文玺凯,张思悦,陈大中,耿雯倩,张叶叶,巩志荣。载盐霉素的聚乙二醇-神经酰胺胶束及其制备方法与应用,专利号:ZL 201510725278.X,公开/公告日期:2018.08.24 7. 俞媛;钟延强,耿雯倩;鲁莹;邹豪;高洁;陈琰;张翮;孙治国;解方园。一种脑靶向的仿生纳米药物递释系统的制备及在治疗脑胶质瘤中的应用,专利号:ZL 201510500260.X,公开/公告日期: 2018.02.09 8. 高洁;戴丹栋;沈贤;解方园;尹又。 LPD纳米脂质体及其制备方法和应用。专利号:ZL202110375361.4, 公开/公告日期:2022.9.5 9. 潘向强;李文靖;高洁;武艳;贝颖;李梦;朱健。一种按需降解的聚多巴胺交联聚乙二醇水凝胶材料及其制备方法与应用。专 利 号:ZL 2022 1 0929063.X;公告日:2023.06.02
|